Cucurbitacin IIa exerts antidepressant-like effects on mice exposed to chronic unpredictable mild stress

Abstract

Cucurbitacin IIa (CuIIa) is the major active component of the Helmseya amabilis root and is known to have antiviral and anti-inflammatory effects. In this study, we examined the antidepressant-like effects of CuIIa in a mouse model of chronic unpredictable mild stress (CUMS) and investigated the possible underlying mechanisms. To evaluate the antidepressant-like effects of CuIIa on depression-like behaviors, mice were subjected to the open-field test, the elevated plus-maze test, the forced-swimming test, and the tail-suspension test. We found that CuIIa treatment reversed the CUMS-induced behavioral abnormalities. Western blot analyses showed that CUMS significantly decreased brain-derived neurotrophic factor (BDNF) levels, cAMP-response element binding protein (CREB), and calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylation, and N-methyl-D-aspartate receptor subtype GluN2B and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluA1 expression in the amygdala; in addition, the expression of gamma-aminobutyric acid receptor A subunit α2 was upregulated in CUMS mice. These CUMS-induced changes were all normalized by CuIIa treatment and administration of the BDNF antagonist ANA-12 can block the antidepressant effect of CuIIa. Our findings suggest that the antidepressant-like effects of CuIIa may be exerted by regulation of the CaMKIIα-CREB-BDNF pathway and the balance between excitatory and inhibitory synaptic transmission in the amygdala.

Anxiolytic effects of polydatin through the blockade of neuroinflammation in a chronic pain mouse model

“…The anxious degree was evaluated by the number of entries and the time spent in open arms. 22 EPM test was performed after OF test on the same day in the morning.…”

Gemfibrozil has antidepressant effects in mice: Involvement of the hippocampal brain-derived neurotrophic factor system

“…The CUMS model of depression was established according to previous studies with some modifications (Jiang et al, 2012; Kim et al, 2017; Zhou et al, 2017). Control mice were left undisturbed in home cages in a separate room, while stressed mice were housed individually and exposed to CUMS for 8 weeks.…”

The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders

“…However, the olfactory bulbectomized rats showed a decrease in the level of CaMKIIα in the hippocampus [ 120 , 121 ]. Moreover, the unpredictable chronic mild stress procedure diminished the CaMKIIα level in mice [ 122 ]. It seems that CaMKII isoforms may play opposite roles in the development of depressive-like phenotype.…”